SCHEMBL18955434

SCHEMBL18955434

COc1ccc(CN2C(=O)C(=O)c3cc(S(=O)(=O)[O-])ccc32)cc1.[Na+]

nearest known ligand 0.78

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA12 known ✓ O43570 6/20 0.78
CA1 known ✓ P00915 6/20 0.78
CA2 known ✓ P00918 6/20 0.78
CA9 Q16790 6/20 0.78
CHRM5 P08912 4/20 0.64
CASP3 P42574 7/20 0.60
CASP7 P55210 6/20 0.60
CLTC Q00610 1/20 0.57
TP53 P04637 1/20 0.53
MAPT P10636 1/20 0.53
CASP1 P29466 2/20 0.52
CASP6 P55212 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18955136 0.88 CA1 (1.00) CA12CA1CA2CA9CHRM5
SCHEMBL18955436 0.87 CA12 (0.77) CA12CA1CA2CA9CHRM5
SCHEMBL18954814 0.83 CA1 (0.59) CA12CA1CA2CA9CASP3
SCHEMBL3021031 0.81 CHRM5 (0.72) CA12CA1CA2CA9CHRM5
SCHEMBL4735891 0.81 CHRM5 (0.68) CA12CA1CA2CA9CHRM5
SCHEMBL18954967 0.81 CTRB1 (0.63) CA12CA1CA2CA9CASP3
SCHEMBL18954687 0.81 CA1 (0.57) CA12CA1CA2CA9CASP3
SCHEMBL5429061 0.79 CHRM5 (0.72) CA12CA1CA2CA9CHRM5
SCHEMBL18954736 0.79 CA1 (0.62) CA12CA1CA2CA9CASP3
SCHEMBL578232 0.78 PARK7 (0.76) CA12CA1CA2CA9CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 WO disclosed